Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026)
Alnylam Pharmaceuticals (ALNY) has disclosed Change in Inventory for 9 consecutive years, with $3.3 million as the latest value for Q1 2026.
- For Q1 2026, Change in Inventory rose 153.48% year-over-year to $3.3 million; the TTM value through Mar 2026 reached $1.1 million, up 105.38%, while the annual FY2025 figure was -$8.5 million, 37.65% up from the prior year.
- Change in Inventory hit $3.3 million in Q1 2026 for Alnylam Pharmaceuticals, down from $13.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $19.0 million in Q4 2022 and bottomed at -$12.0 million in Q4 2023.
- Average Change in Inventory over 5 years is -$174764.7, with a median of -$1.9 million recorded in 2022.
- On a YoY basis, Change in Inventory climbed as much as 1732.63% in 2025 and fell as far as 28150.0% in 2025.
- Alnylam Pharmaceuticals' Change in Inventory stood at $19.0 million in 2022, then tumbled by 163.18% to -$12.0 million in 2023, then skyrocketed by 92.92% to -$849000.0 in 2024, then surged by 1732.63% to $13.9 million in 2025, then crashed by 76.02% to $3.3 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods came in at $3.3 million, $13.9 million, and -$5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.